These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7418184)

  • 1. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.
    Rinkenberger RL; Prystowsky EN; Heger JJ; Troup PJ; Jackman WM; Zipes DP
    Circulation; 1980 Nov; 62(5):996-1010. PubMed ID: 7418184
    [No Abstract]   [Full Text] [Related]  

  • 2. Verapamil in cardiac arrhythmias: an overview.
    Vohra J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():129-34. PubMed ID: 6749351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supraventricular tachycardias.
    Wu D
    JAMA; 1983 Jun; 249(24):3357-60. PubMed ID: 6854872
    [No Abstract]   [Full Text] [Related]  

  • 4. Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.
    Rabkin SW; Tomlinson C; Corbett BN; Cuddy TE
    Can Med Assoc J; 1980 Jan; 122(1):64-8. PubMed ID: 7363198
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.
    Heng MK; Singh BN; Roche AH; Norris RM; Mercer CJ
    Am Heart J; 1975 Oct; 90(4):487-98. PubMed ID: 1163442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General aspects of anti-arrhythmic treatment with aprindine.
    Kesteloot H
    Acta Cardiol; 1974; Suppl 18():303-16. PubMed ID: 4138773
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of arrhythmias with "calcium antagonists".
    Zipes DP; Gilmour RF
    Angiology; 1982 Aug; 33(8):540-54. PubMed ID: 6287890
    [No Abstract]   [Full Text] [Related]  

  • 8. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
    Krikler DM
    Minerva Med; 1975 May; 66(39):1914-22. PubMed ID: 236526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
    Hiejima K; Suzuki F; Takahashi M; Satake S
    Jpn Circ J; 1983 Jan; 47(1):98-104. PubMed ID: 6827776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical use of intravenous verapamil.
    Schamroth L
    Am Heart J; 1980 Dec; 100(6 Pt 2):1070-5. PubMed ID: 7004158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissimilar atrial rhythms in a patient with the Wolff-Parkinson-White syndrome.
    Genetos BC; Gaum WE; Etharrar V; Zipes DP
    Chest; 1977 Nov; 72(5):663-6. PubMed ID: 913153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
    Hamer A; Peter T; Platt M; Mandel WJ
    Am Heart J; 1981 May; 101(5):600-12. PubMed ID: 7223599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration of a major preexcitation syndrome during treatment of auricular flutter using intravenous injection of verapamil].
    Chaudron JM; Lebacq E
    Acta Cardiol; 1975; 30(2):137-50. PubMed ID: 1079999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory supraventricular tachycardias.
    Ticzon AR; Whalen RW
    Circulation; 1973 Mar; 47(3):642-53. PubMed ID: 4571059
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with verapamil.
    Vohra J; Hunt D; Sloman G
    Med J Aust; 1975 Sep; 2(11):417-21. PubMed ID: 1186549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of patients with recurrence of ventricular tachyarrhythmias for electrical studies.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR
    Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 2):499-504. PubMed ID: 6204307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Re-evaluation of the use of verapamil in supraventricular tachyarrhythmias].
    Carvalho MA; Osterne EC; Bezerra FA; Carvalho PR; Barros RB; Carneiro RD
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():83-6. PubMed ID: 678167
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleterious effects of intravenous verapamil in Wolff-Parkinson-White patients and atrial fibrillation.
    Strasberg B; Sagie A; Rechavia E; Katz A; Ovsyscher IA; Sclarovsky S; Agmon J
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):801-6. PubMed ID: 2488095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.